Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Capital Expenditures: 2022-2025

Historic Capital Expenditures for Praxis Precision Medicines (PRAX) over the last 1 years, with Sep 2025 value amounting to -$8,000.

  • Praxis Precision Medicines' Capital Expenditures was N/A to -$8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $151,000, marking a year-over-year change of. This contributed to the annual value of $50,000 for FY2023, which is 88.74% down from last year.
  • Praxis Precision Medicines' Capital Expenditures amounted to -$8,000 in Q3 2025, which was down 112.50% from $64,000 recorded in Q1 2025.
  • Over the past 5 years, Praxis Precision Medicines' Capital Expenditures peaked at $289,000 during Q1 2022, and registered a low of -$8,000 during Q3 2025.
  • Over the past 2 years, Praxis Precision Medicines' median Capital Expenditures value was $50,000 (recorded in 2023), while the average stood at $35,333.
  • Data for Praxis Precision Medicines' Capital Expenditures shows a peak YoY rose of 11.11% (in 2023) over the last 5 years.
  • Over the past 3 years, Praxis Precision Medicines' Capital Expenditures (Quarterly) stood at $45,000 in 2022, then rose by 11.11% to $50,000 in 2023, then reached -$8,000 in 2025.
  • Its Capital Expenditures stands at -$8,000 for Q3 2025, versus $64,000 for Q1 2025 and $50,000 for Q3 2023.